In ESCC, PP242 can inhibit mTORC1 and mTORC2 pathways and regulate the constitutive activation of Akt induced by cisplatin, thus enhancing the anti-tumor effect of chemotherapy drug cisplatin. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.